North America Chronic Cough Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, and Other Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Country

No. of Pages: 97
Report Code: TIPRE00013291
Category: Life Sciences
North America Chronic Cough Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Chronic Cough Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Chronic Cough Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Chronic Cough Market Regional Analysis

6.2 North America Chronic Cough Market Revenue 2017-2027 (US$ Million)
6.3 North America Chronic Cough Market Forecast Analysis

7. North America Chronic Cough Market Analysis – by Drug Class

7.1 Antihistamines
  • 7.1.1 Overview
  • 7.1.2 Antihistamines: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Corticosteroids
  • 7.2.1 Overview
  • 7.2.2 Corticosteroids: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Decongestants
  • 7.3.1 Overview
  • 7.3.2 Decongestants: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Combination Drug
  • 7.4.1 Overview
  • 7.4.2 Combination Drug: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Antibiotics
  • 7.5.1 Overview
  • 7.5.2 Antibiotics: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Acid Blockers
  • 7.6.1 Overview
  • 7.6.2 Acid Blockers: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Other Drug Class
  • 7.7.1 Overview
  • 7.7.2 Other Drug Class: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Chronic Cough Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Injections
  • 8.2.1 Overview
  • 8.2.2 Injections: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalation
  • 8.3.1 Overview
  • 8.3.2 Inhalation: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Other Route of Administration
  • 8.4.1 Overview
  • 8.4.2 Other Route of Administration: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Chronic Cough Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Online Pharmacy
  • 9.2.1 Overview
  • 9.2.2 Online Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Retail Pharmacy
  • 9.3.1 Overview
  • 9.3.2 Retail Pharmacy: North America Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Chronic Cough Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Chronic Cough Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 North America Chronic Cough Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 US: North America Chronic Cough Market Breakdown, by Drug Class
    • 10.2.1.1.2 US: North America Chronic Cough Market Breakdown, by Route of Administration
    • 10.2.1.1.3 US: North America Chronic Cough Market Breakdown, by Distribution Channel
  • 10.2.1.2 Canada: North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Canada: North America Chronic Cough Market Breakdown, by Drug Class
    • 10.2.1.2.2 Canada: North America Chronic Cough Market Breakdown, by Route of Administration
    • 10.2.1.2.3 Canada: North America Chronic Cough Market Breakdown, by Distribution Channel
  • 10.2.1.3 Mexico : North America Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Chronic Cough Market Breakdown, by Drug Class
    • 10.2.1.3.2 Mexico : North America Chronic Cough Market Breakdown, by Route of Administration
    • 10.2.1.3.3 Mexico : North America Chronic Cough Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Novartis AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Teva Pharmaceutical Industries Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bayer AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Mylan N.V.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Amneal Pharmaceuticals, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cipla Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Reckitt Benckiser Group plc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Aurobindo Pharma Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Chronic Cough Market

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)